Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.

Real Housewives of Beverly Hills alum Teddi Mellencamp shared her heartbreaking reaction after a fan weighed in on her ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...

A 40-gene expression profile (40-GEP) test can improve risk stratification of patients with cutaneous squamous cell carcinoma (CSCC), according to research presented at the NCCN Annual Conference 2025 ...

The supervisory board of the Company has reviewed the financial statements 2024 on April 2nd, 2025 and the Company's ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...